This inventor holds 1 USPTO granted patent. Top assignee: Industrial Cooperation Foundation Jeonbuk National University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Eun Kyeong Jung and a Retinoic Acid-Based Anticancer Invention.
Introduction
Eun Kyeong Jung is an inventor associated with Suncheon-si, South Korea. Her work includes a patent describing a retinoic acid prodrug designed for use in an anticancer drug composition.
Latest Patents
Jung is listed as an inventor on 1 patent: “Retinoic Acid Precursor and Anticancer Drug Composition Comprising Same.” The invention describes a retinoic acid prodrug bound to a boron functional group. The prodrug can self-assemble into nanoparticles, which may serve as the active ingredient in an anticancer composition. The patent describes a proposed synergistic anticancer effect from retinoic acid and the boron functional group, along with particle surface modification intended to support targeted treatment of tumor cells. It also reports that the prodrug enables a drug loading of 100 wt%.
Career Highlights
Jung is associated with the Industrial Cooperation Foundation of Jeonbuk National University. The available information identifies her contribution to the patented anticancer drug technology but does not provide further details about her career.
Collaborations
Dong Won Lee is identified as Jung’s coworker. The supplied information does not specify the nature of their collaboration or their respective roles in the patent.
Conclusion
Eun Kyeong Jung’s listed patent presents a nanoparticle-forming retinoic acid prodrug concept that combines a boron functional group with a proposed approach to targeted anticancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile